Provided by Tiger Fintech (Singapore) Pte. Ltd.

Genmab A/S

22.03
-0.8300-3.63%
Post-market: 22.030.00000.00%17:22 EDT
Volume:1.57M
Turnover:34.79M
Market Cap:13.57B
PE:12.00
High:22.43
Open:22.39
Low:22.02
Close:22.86
Loading ...

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
15 May

Genmab A/S Stock Rises Monday, Underperforms Market

Dow Jones
·
13 May

Genmab A/S Stock Rises Friday, Outperforms Market

Dow Jones
·
10 May

Genmab Q1 EPS $0.31 Beats $0.23 Estimate, Sales $715.00M Miss $748.58M Estimate

Benzinga
·
09 May

Genmab A/S reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Genmab Q1 Earnings, Revenue Increase

MT Newswires Live
·
08 May

Stock Track | Genmab A/S Plummets 5.90% Despite 19% Revenue Growth in Q1 2025 Results

Stock Track
·
08 May

Stock Track | Genmab A/S Shares Plummet 5.90% Despite Positive Q1 Results, Investors Seek More Growth

Stock Track
·
08 May

Genmab reaffirms FY25 guidance

TIPRANKS
·
08 May

Earnings Flash (GMAB) Genmab Posts Q1 EPS $3.05

MT Newswires Live
·
08 May

Earnings Flash (GMAB) Genmab Posts Q1 Revenue $715M, vs. FactSet Est of $735.9M

MT Newswires Live
·
08 May

Press Release: Genmab Announces Financial Results for the First Quarter of 2024

Dow Jones
·
08 May

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
08 May

Genmab A/S expected to post earnings of 24 cents a share - Earnings Preview

Reuters
·
06 May

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
06 May

Transactions in Connection with Share Buy-back Program

GlobeNewswire
·
05 May

Genmab A/S Stock Rises Friday, Underperforms Market

Dow Jones
·
03 May

Sector Update: Health Care Stocks Rise Premarket Friday

MT Newswires Live
·
02 May

Genmab to Seek FDA Review of Follicular Lymphoma Combination Therapy

MT Newswires Live
·
02 May

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB) and Envista Holdings (NVST)

TIPRANKS
·
02 May